MSF at the International Aids Society Conference on HIV – 2017

MSF at IAS 2017

Download the MSF@IAS2017 brochure

Download the MSF@IAS2017 abstracts book

Médecins Sans Frontières (MSF) is participating in the world's largest biannual scientific HIV conference, run by the International Aids Society (IAS). The conference will take place in Paris from 23 to 26 July.

At IAS 2017, MSF will share operational research related to advanced HIV, with a focus on reasons for seeking and remaining in treatment, diagnostic tools, viral load testing and opportunistic infections, especially tuberculosis. Field realities from low coverage settings (Guinea, DRC, South Sudan) and high coverage settings in East and South Africa (Uganda, Kenya, Malawi, Mozambique) will also be shared, along with the latest reporting on drug pricing trends and threats to access to HIV treatment.

AIDS

MSF continues to see unacceptably high number of people with advanced HIV (CD4<200) in its hospitals in Sub-Saharan Africa. In MSF-run and MSF-supported hospitals in Guinea, DRC, Kenya and Malawi, we witness a 30-40% mortality rate among HIV patients. More than 50% of hospital admissions for advanced HIV are for patients with prior antiretroviral exposure. But advanced HIV and therapeutic failure no longer need to be synonymous with death. Recovering from advanced HIV is possible with swift action at community, primary care and hospital level; routine viral load and continued CD4 monitoring and point-of-care rapid diagnostic tools are needed, along with access to affordable, effective treatment for opportunistic diseases.

Clinicians call

Download the briefing paper Waiting isn’t an Option: Preventing and Surviving Advanced HIV

MSF Satellite Session

Waiting isn’t an Option: Preventing and Surviving Advanced HIV
Organised by MSF
Sunday 23 July 12:30-14:30 / Maillot Room

West and Central Africa

The West and Central Africa region accounts for 45% of children born with HIV, 27% of the global AIDS related deaths and 21% of global new infections. Huge disparities exist in the treatment cascades for the region (36% 28% and 12%) compared to eastern and southern Africa (66% 54% and 45%). In 2015, out of the 6.5 million people living with HIV in the region, 4.7 million were not accessing treatment. Yet, priority is given to higher disease burden countries. The session convenes governments, scientists, donors and civil society organizations, as urgent joint action is needed and solutions exist. This event highlights evidence on best practices and models of care to accelerate access to treatment and improve quality of care.

Download the briefing paper No time to lose: overcoming barriers of acceleration of HIV treatment

MSF Satellite Session:

West & Central Africa:  Making the Case for a Region-Specific Solution
Organised by MSF, WHO and UNAIDS
Sunday 23 July 10:15-12:15 / Maillot Room

Threats to HIV Treatments Scale-up

At a time when existing evidence must rapidly be translated into practice, international funding for the HIV response is in decline. Hard won gains may be lost as countries facing funding gaps have to make difficult choices in rationing treatment and delaying investments in strategies that have been shown to work.  It will be impossible to achieve global health targets - including for HIV- without increasing national and international assistance.

Download the briefing paper MSF Issue brief: Threats to HIV treatment scale-up

Press Room

Press Conference

Dying of AIDS in the era of antiretrovirals

Speakers: Dr Eric Goemaere, Dr Stephen Wanjala, Dr Amir Shroufi

Tuesday 25 July, 12:00-12:45 / Press Conference Room (Level 3)

Le Palais des Congrès, 2 Place de la Porte Maillot, 75017 Paris

Press release

Press contact:
Charlotte Morris
+44  75.87.55.35.39
Charlotte.Morris@london.msf.org

Download HIV-related ALL USES photos

Follow @MSF_HIV on Twitter for realtime updates

Access Campaign

Read the latest on the challenges people living with HIV have in accessing adequate and effective diagnostics tests and drugs for HIV and AIDS-related opportunistic infections, such as TB and CCM.

RESOURCES

Download MSF HIV-related reports:

90-90-90

Access to patients

ART

Viral Load